Table 4 Correlation of patient characteristics with sinus rate (RR interval) and AV conduction measurements during sedation

Group (Pro—Dex)

-116 (-191 to -41)

0.003

-20 (-33 to -8)

0.002

-15 (-26 to -4)

0.008

-56 (-95 to -17)

0.006

Age

5.80 (2.64 to 8.96)

 < 0.001

1.04 (0.53 to 1.56)

 < 0.001

0.62 (0.07 to 1.17)

0.027

1.63 (-0.11 to 3.36)

0.065

Gender

-28.5 (-105.6 to 48.6)

0.466

9.5 (-4.2 to 23.3)

0.172

9.0 (-4.3 to 22.4)

0.183

7.7 (-33.2 to 48.6)

0.710

Hypertension

20.7 (-56.7 to 98.1)

0.598

14.8 (2.1 to 27.4)

0.023

9.6 (-1.6 to 20.8)

0.094

33.1 (-6.0 to 72.1)

0.096

Diabetes

-32.4 (-172.1 to 07.3)

0.648

7.6 (-14.9 to 30.1)

0.506

-2.5 (-18.7 to 13.6)

0.759

-27.4 (-83.0 to 28.2)

0.332

CAD

-86.2 (-193.0 to 20.5)

0.113

-1.9 (-19.9 to 16.2)

0.839

7.3 (-8.9 to 23.5)

0.376

17.8 (-30.3 to 65.8)

0.465

Hx of CHF

-60.7 (-182.0 to 60.7)

0.325

18.6 (-5.2 to 42.5)

0.125

11.4 (-7.6 to 30.4)

0.238

16.9 (-50.6 to 84.4)

0.622

OSAS

-44.4 (-162.9 to 74.2)

0.461

-0.7 (-20.0 to 18.7)

0.947

0.6 (-12.0 to 13.3

0.925

37.3 (-50.6 to 125.2)

0.403

LVEF

1.35 (-2.68 to 5.38)

0.508

0.37 (-0.50 to 1.24)

0.404

0.47 (-0.21 to 1.14)

0.173

0.91 (-1.76 to 3.58)

0.501

LAVI

3.94 (0.80 to 7.09)

0.014

0.73 (0.17 to 1.28)

0.010

0.35 (-0.20 to 0.90)

0.208

2.18 (0.40 to 3.96)

0.017

Betablocker

23.4 (-59.4 to 106.2)

0.577

2.2 (-11.3 to 15.7)

0.744

-6.3 (-18.5 to 5.8)

0.305

-40.4 (-82.4 to 1.6)

0.059

Procedure duration

-0.18 (-0.77 to 0.42)

0.557

-0.01 (-0.11 to 0.10)

0.915

-0.04 (-0.13 to 0.05)

0.385

-0.18 (-0.48 to 0.13)

0.254